3',4'-Dihydroxyflavonol Modulates the Cell Cycle in Cancer Cells: Implication as a Potential Combination Drug in Osteosarcoma

• Main Authors: José Miguel P. Ferreira de Oliveira (Author), Joana Filipa D. Almeida (Author), Maria Martins (Author), Carina Proença (Author), Helena Oliveira (Author), Eduarda Fernandes (Author), Conceição Santos (Author)
• Format: Book
• Published: MDPI AG, 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

New agents are demanded to increase the therapeutic options for osteosarcoma (OS). Although OS is the most common bone cancer in children and adolescents, it is considered a rare disorder. Therefore, finding adjuvant drugs has potential to advance therapy for this disease. In this study, 3',4&#...